retatrutide heartburn Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide - “Triple G” |
Description
2013;8(4): e60546

PCOS is strongly associated with insulin resistance and obesity, both of which can impair ovulation

GLP-1 receptor agonists include medications such as semaglutide, dulaglutide, and liraglutide, which are typically administered by subcutaneous injection (though oral semaglutide is available)
The results consistently showed that patients can take considerably less of the GLP-1 drug and still reap the majority of their weight loss benefits

Mechanism of action and novelty: Newer agents with more complex mechanisms such as dual or triple receptor agonists tend to be priced at a premium compared with established treatments
